Peptides for Inflammation
The peptides people most often research for inflammation, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 5
- With human trials
- 1
- FDA approved (any use)
- 1
- BPC-157Gastric pentadecapeptideAnimal evidence, 2 of 4Journal of physiology and pharmacology 2013, PMID 24304574Human8Animal43Summarised2PCAC voted 8–6 for 503A (Jul 2026)For inflammationOverview
- TirzepatideGLP-1 / GIP dual agonistNo study with an outcome for inflammationPubMed search, 2 Oct 2026Human85Animal37Summarised1FDA approved (Mounjaro, Zepbound)For inflammationOverview
- KPVAnti-inflammatory tripeptideAnimal evidence, 2 of 4Inflammatory bowel diseases 2008, PMID 18092346Human10Animal19Summarised6PCAC voted 8–6 for 503A (Jul 2026)For inflammationOverview
- TB-500Synthetic fragment of thymosin beta-4Human RCT evidence, 4 of 4Microbial biotechnology 2021, PMID 34318587Human78Animal80Summarised2PCAC voted 8–6 for 503A (Jul 2026)For inflammationOverview
- GHK-CuCopper tripeptideAnimal evidence, 2 of 4Frontiers in pharmacology 2025, PMID 40672369Human13Animal12Summarised3Injectable off Category 2 (Apr 2026)For inflammationOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What inflammation is
MedlinePlus calls inflammation the body's way of protecting tissues and helping them heal from an injury, infection or other disease.[20]
It adds that short-lived inflammation is helpful, while inflammation that lasts too long can damage healthy tissue, which is why the useful question for any peptide is which kind of inflammation a study measured.[20]
Which listed peptides have human data on inflammation
PubMed records matching the site's inflammation search: BPC-157 8 human-only and 43 animal-only; Tirzepatide 85 human-only and 37 animal-only; KPV 10 human-only and 19 animal-only; TB-500 78 human-only and 80 animal-only; GHK-Cu 13 human-only and 12 animal-only.
Calculated from goal inflammation; ledger date 2026-10-02; counts bpc-157 (human only 8, animal 43, rct 0), tirzepatide (human only 85, animal 37, rct 8), kpv (human only 10, animal 19, rct 0), tb-500 (human only 78, animal 80, rct 1), ghk-cu (human only 13, animal 12, rct 0). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
Tirzepatide has the only human inflammation-marker data in the group: a meta-analysis of seven randomized trials and one observational study reported lower hsCRP and IL-6 than placebo, though these are blood markers rather than symptoms.[21]
For BPC-157 the inflammation findings are from rats: in a periodontitis model, treatment reduced plasma extravasation, tissue changes and bone resorption.[22]
KPV results come from mice and cultured cells: oral KPV reduced the incidence of experimental colitis and lowered pro-inflammatory cytokine expression, with no human trial found for it in inflammation.[23]
GHK-Cu was tested in mouse colitis, where it reduced weight loss and colonic damage and suppressed TNF-alpha, IL-6 and IL-1 beta, again in animals only.[4]
Common questions
What is the best peptide for inflammation?
No peptide here has been shown in a human trial to treat an inflammatory disease; the closest human data are tirzepatide's effects on hsCRP and IL-6, which are lab markers.[21]
Are anti-inflammatory peptides proven in people?
KPV is the clearest example of the gap: its anti-inflammatory results are in mouse colitis and cell lines, including an airway cell line where it blocked NF-kB signalling.[24]
Does a lower CRP mean inflammation is treated?
MedlinePlus says a CRP result shows how much inflammation is present but not what is causing it or where it is, so a change in CRP alone does not identify the condition being treated.[20]
Explore nearby goals
Sources
- 1Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
- 2Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
- 3Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
- 4Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.Frontiers in pharmacology · 2025PMID 40672369Accessed 2 Oct 2026
- 5PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 17PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 18PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 19PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 20Official web pageOfficial web page · web page
- 21Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis.Reviews in endocrine & metabolic disorders · 2026PMID 41032183Accessed 2 Oct 2026
- 22Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2009PMID 20388954Accessed 2 Oct 2026
- 23PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.Gastroenterology · 2008PMID 18061177Accessed 2 Oct 2026
- 24Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.International journal of physiology, pathophysiology and pharmacology · 2012PMID 22837805Accessed 2 Oct 2026
Found an error? Report a correction.